Literature DB >> 27840708

Crystal structure of 2-oxo-2H-chromen-3-yl propano-ate.

Eric Ziki1, Jules Yoda2, Abdoulaye Djandé2, Adama Saba2, Rita Kakou-Yao1.   

Abstract

In the title compound, C12H10O4, the dihedral angle between the coumarin ring system [maximum deviation = 0.033 (8) Å] and the propionate side chain is 78.48 (8)°. In the crystal, weak C-H⋯O hydrogen bonds generate inversion dimers and and C-H⋯π and π-π inter-actions link the dimers into a three-dimensional network. A quantum chemical calculation is in good agreement with the observed structure.

Entities:  

Keywords:  C—H⋯π inter­actions; chromane; crystal structure; quantum-chemical calculations; π–π inter­actions

Year:  2016        PMID: 27840708      PMCID: PMC5095833          DOI: 10.1107/S2056989016015279

Source DB:  PubMed          Journal:  Acta Crystallogr E Crystallogr Commun


Chemical context

Coumarin and its derivatives are widely recognized for their multiple biological activities, including anti­cancer (Lacy et al., 2004 ▸; Kostova, 2005 ▸), anti-inflammatory (Todeschini et al., 1998 ▸), anti­viral (Borges et al., 2005 ▸), anti­malarial (Agarwal et al., 2005 ▸) and anti­coagulant (Maurer et al., 1998 ▸) properties. As part of our studies in this area, we now describe the synthesis and crystal structure of the title compound, (I).

Structural commentary

In compound (I) (Fig. 1 ▸), the coumarin ring system is almost planar [maximum deviation = 0.033 (1)Å] and is oriented at an angle of 70.84 (8)° with respect to the plane formed by the propano­ate group. An inspection of the bond lengths shows that there is a slight asymmetry of the electronic distribution around the coumarin ring: the C2—C3 [1.329 (2) Å] and C2—C1 [1.460 (2) Å] bond lengths are shorter and longer, respectively, than those expected for a Car—Car bond. This suggests that the electron density is preferentially located in the C2—C3 bond at the pyrone ring, as seen in other coumarin-3-carboxamide derivatives (Gomes et al., 2016 ▸).
Figure 1

The mol­ecular structure of compound (I), with displacement ellipsoids drawn at the 50% probability level.

Supra­molecular features

In the crystal, the mol­ecules are linked by pairs of C8—H8⋯O2(x, −y, 1 − z) weak hydrogen bonds to form (12) loops, which lie in a chain running along the c axis direction (Fig. 2 ▸). Weak aromatic π–π stacking inter­actions of 3.7956 (8) Å (Janiak, 2000 ▸) are present between the coumarin pyran ring (centroid Cg1) and benzene ring (centroid Cg2) of symmetry-related (−x, 1 − y, 1 − z) mol­ecules, thus forming a three-dimensional supra­molecular network. A weak C—H⋯Cg (π–ring) inter­action is also present (Figs. 3 ▸ and 4 ▸, and Table 1 ▸).
Figure 2

View of an inversion dimer linked by a pair of C8—H8⋯O2 (−x, −y, −z + 1) inter­actions, generating an (12) loop. This dimers stack by unit translation along the c axis. H atoms not involved in hydrogen bonding have been omitted.

Figure 3

A view of the crystal packing, showing the π–π stacking and C—H⋯π inter­actions (dashed lines). The green dots are ring centroids. H atoms not involved in the C—H⋯π inter­actions have been omitted for clarity.

Figure 4

Part of the crystal structure of (I), showing C—H⋯π and π–π inter­actions as dashed lines. H atoms have been omitted for clarity.

Table 1

Hydrogen-bond geometry (Å, °)

Cg2 is the centroid of the C4–C9 ring.

D—H⋯A D—HH⋯A DA D—H⋯A
C8—H8⋯O2i 0.932.593.4783 (19)161
C5—H5⋯Cg2ii 0.932.783.4959 (16)134

Symmetry codes: (i) ; (ii) .

Theoretical calculations

Quantum-chemical calculations were performed to compare with the experimental analysis. An ab-initio Hartree–Fock (HF) method was used with the standard basis set of 6-31G using the GAUSSIAN03 software package (Frisch et al., 2004 ▸; Dennington et al., 2007 ▸) to obtain the optimized mol­ecular structure. The computational results are in good agreement with the experimental crystallographic data (Table 2 ▸).
Table 2

Experimental and calculated bond lengths (Å)

BondX-rayHF(6–31G)
O1—C11.3628 (17)1.371
O1—C91.3769 (17)1.378
O2—C11.2004 (18)1.227
O3—C101.3713 (18)1.359
O3—C21.3893 (17)1.381
O4—C101.1932 (19)1.21
C1—C21.460 (2)1.468
C2—C31.329 (2)1.355
C3—C41.4403 (19)1.441
C4—C51.401 (2)1.406
C4—C91.3928 (18)1.407
C5—C61.370 (2)1.387
C6—C71.386 (2)1.395
C7—C81.379 (2)1.383
C8—C91.3842 (19)1.408
C10—C111.495 (2)1.497
C11—C121.491 (3)1.525

Synthesis and crystallization

In a 100 ml round-necked flask topped with a water condenser were introduced successively 25 ml of dried diethyl ether, 6.17 × 10 −3 mol (≃ 0.8 ml) of propionic anhydride and 2.35 ml (4.7 molar equivalents) of dried pyridine. While stirring strongly, 6.17 × 10−3 mol (1 g) of 3-hy­droxy­coumarin was added in small portions over 30 min. The reaction mixture was left under agitation at room temperature for 3 h. The mixture was then poured in a separating funnel containing 40 ml of chloro­form and washed with diluted hydro­chloric acid solution until the pH was 2–3. The organic layer was extracted, washed with water to neutrality, dried over MgSO4 and the solvent removed. The resulting precipitate (crude product) was filtered off with petroleum ether and recrystallized from a solvent mixture of chloro­form–hexane (1/3, v/v). Colourless prisms of the title compound were obtained in a yield of 65%, m. p. = 351–353 K.

Refinement

Crystal data, data collection and structure refinement details are summarized in Table 3 ▸. H atoms were placed in calculated positions [C—H = 0.93 (aromatic), 0.96 (meth­yl) or 0.97 Å (methyl­ene)] and refined using a riding-model approximation with U iso(H) constrained to 1.2 (aromatic and methyl­ene group) or 1.5 (methyl group) times U eq of the respective parent atom.
Table 3

Experimental details

Crystal data
Chemical formulaC12H10O4
M r 218.20
Crystal system, space groupMonoclinic, P21/c
Temperature (K)293
a, b, c (Å)12.1179 (4), 5.7243 (2), 15.3275 (5)
β (°)94.881 (3)
V3)1059.36 (6)
Z 4
Radiation typeCu Kα
μ (mm−1)0.87
Crystal size (mm)0.46 × 0.16 × 0.08
 
Data collection
DiffractometerAgilent SuperNova Dual (Cu at zero) Source diffractometer with an AtlasS2 detector
Absorption correctionMulti-scan (CrysAlis PRO; Agilent, 2014)
T min, T max 0.778, 1.000
No. of measured, independent and observed [I > 2σ(I)] reflections6028, 1930, 1655
R int 0.020
(sin θ/λ)max−1)0.605
 
Refinement
R[F 2 > 2σ(F 2)], wR(F 2), S 0.038, 0.117, 1.06
No. of reflections1930
No. of parameters145
H-atom treatmentH-atom parameters constrained
Δρmax, Δρmin (e Å−3)0.16, −0.16

Computer programs: CrysAlis PRO (Agilent, 2014 ▸), SHELXS97 (Sheldrick, 2008 ▸), SHELXL2013 (Sheldrick, 2015 ▸), PLATON (Spek, 2009 ▸) and publCIF (Westrip, 2010 ▸).

Crystal structure: contains datablock(s) I, New_Global_Publ_Block. DOI: 10.1107/S2056989016015279/hb7613sup1.cif Structure factors: contains datablock(s) I. DOI: 10.1107/S2056989016015279/hb7613Isup2.hkl Click here for additional data file. Supporting information file. DOI: 10.1107/S2056989016015279/hb7613Isup3.cml CCDC reference: 1507161 Additional supporting information: crystallographic information; 3D view; checkCIF report
C12H10O4F(000) = 456
Mr = 218.20Dx = 1.368 Mg m3
Monoclinic, P21/cMelting point: 351 K
Hall symbol: -P 2ybcCu Kα radiation, λ = 1.54184 Å
a = 12.1179 (4) ÅCell parameters from 3028 reflections
b = 5.7243 (2) Åθ = 5.8–68.6°
c = 15.3275 (5) ŵ = 0.87 mm1
β = 94.881 (3)°T = 293 K
V = 1059.36 (6) Å3Prism, colourless
Z = 40.46 × 0.16 × 0.08 mm
Agilent SuperNova Dual (Cu at zero) Source diffractometer with an AtlasS2 detector1930 independent reflections
Radiation source: sealed X-ray tube1655 reflections with I > 2σ(I)
Mirror monochromatorRint = 0.020
Detector resolution: 5.3048 pixels mm-1θmax = 68.9°, θmin = 3.7°
ω scanh = −14→14
Absorption correction: multi-scan (CrysAlis PRO; Agilent, 2014)k = −6→6
Tmin = 0.778, Tmax = 1.000l = −15→18
6028 measured reflections
Refinement on F2Primary atom site location: structure-invariant direct methods
Least-squares matrix: fullSecondary atom site location: difference Fourier map
R[F2 > 2σ(F2)] = 0.038Hydrogen site location: inferred from neighbouring sites
wR(F2) = 0.117H-atom parameters constrained
S = 1.06w = 1/[σ2(Fo2) + (0.0631P)2 + 0.1085P] where P = (Fo2 + 2Fc2)/3
1930 reflections(Δ/σ)max < 0.001
145 parametersΔρmax = 0.16 e Å3
0 restraintsΔρmin = −0.16 e Å3
40 constraints
Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; correlations between esds in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell esds is used for estimating esds involving l.s. planes.
xyzUiso*/Ueq
O10.08845 (8)0.19504 (17)0.44462 (6)0.0505 (3)
O30.36752 (8)0.39585 (19)0.41680 (7)0.0567 (3)
C90.02550 (11)0.3708 (2)0.40435 (8)0.0426 (3)
C20.25245 (11)0.3964 (2)0.40998 (9)0.0466 (3)
C30.19407 (11)0.5719 (2)0.37284 (8)0.0455 (3)
H30.22980.69850.34970.055*
C40.07494 (11)0.5644 (2)0.36879 (8)0.0420 (3)
C8−0.08834 (12)0.3450 (3)0.40123 (9)0.0521 (3)
H8−0.11980.21500.42580.063*
C10.20130 (12)0.1982 (2)0.45088 (9)0.0492 (3)
O40.36176 (9)0.1032 (2)0.31915 (8)0.0683 (3)
O20.24985 (10)0.0406 (2)0.48893 (8)0.0695 (3)
C50.00553 (12)0.7361 (2)0.32863 (9)0.0497 (3)
H50.03620.86760.30450.060*
C6−0.10727 (13)0.7114 (3)0.32463 (10)0.0566 (4)
H6−0.15270.82570.29750.068*
C7−0.15398 (12)0.5169 (3)0.36080 (10)0.0567 (4)
H7−0.23060.50220.35780.068*
C100.41542 (12)0.2272 (3)0.36892 (10)0.0530 (3)
C110.53858 (13)0.2315 (4)0.38698 (13)0.0728 (5)
H11A0.56440.39050.38080.087*
H11B0.55760.18390.44710.087*
C120.59736 (16)0.0768 (5)0.32791 (15)0.0858 (6)
H12A0.67580.08710.34280.129*
H12B0.58060.12520.26830.129*
H12C0.5736−0.08170.33460.129*
U11U22U33U12U13U23
O10.0500 (5)0.0463 (5)0.0557 (5)−0.0037 (4)0.0068 (4)0.0091 (4)
O30.0398 (5)0.0614 (6)0.0686 (6)−0.0025 (4)0.0019 (4)−0.0145 (5)
C90.0453 (7)0.0438 (6)0.0394 (6)−0.0015 (5)0.0069 (5)−0.0014 (5)
C20.0395 (7)0.0505 (7)0.0499 (7)−0.0036 (5)0.0052 (5)−0.0083 (5)
C30.0468 (7)0.0425 (7)0.0485 (7)−0.0072 (5)0.0109 (5)−0.0037 (5)
C40.0459 (7)0.0411 (6)0.0398 (6)−0.0018 (5)0.0083 (5)−0.0037 (5)
C80.0473 (7)0.0570 (8)0.0535 (7)−0.0083 (6)0.0125 (6)−0.0022 (6)
C10.0506 (7)0.0490 (7)0.0479 (7)0.0031 (6)0.0034 (5)0.0009 (6)
O40.0510 (6)0.0805 (8)0.0730 (7)−0.0006 (5)0.0025 (5)−0.0238 (6)
O20.0665 (7)0.0669 (7)0.0749 (7)0.0122 (6)0.0041 (6)0.0197 (6)
C50.0575 (8)0.0450 (7)0.0474 (7)0.0025 (6)0.0100 (6)0.0013 (5)
C60.0548 (8)0.0611 (9)0.0540 (7)0.0145 (7)0.0065 (6)−0.0010 (6)
C70.0411 (7)0.0715 (9)0.0584 (8)0.0027 (6)0.0097 (6)−0.0069 (7)
C100.0450 (8)0.0594 (8)0.0545 (7)0.0007 (6)0.0038 (6)−0.0053 (6)
C110.0430 (8)0.0917 (13)0.0829 (11)0.0053 (8)−0.0003 (7)−0.0168 (10)
C120.0526 (10)0.1094 (16)0.0951 (13)0.0179 (10)0.0050 (9)−0.0168 (12)
O1—C11.3628 (17)O4—C101.1932 (19)
O1—C91.3769 (17)C5—C61.370 (2)
O3—C101.3713 (18)C5—H50.9300
O3—C21.3893 (17)C6—C71.386 (2)
C9—C81.3842 (19)C6—H60.9300
C9—C41.3926 (18)C7—H70.9300
C2—C31.329 (2)C10—C111.495 (2)
C2—C11.460 (2)C11—C121.491 (3)
C3—C41.4403 (19)C11—H11A0.9700
C3—H30.9300C11—H11B0.9700
C4—C51.401 (2)C12—H12A0.9600
C8—C71.379 (2)C12—H12B0.9600
C8—H80.9300C12—H12C0.9600
C1—O21.2004 (18)
C1—O1—C9122.43 (10)C4—C5—H5119.8
C10—O3—C2115.41 (11)C5—C6—C7120.31 (14)
O1—C9—C8116.74 (12)C5—C6—H6119.8
O1—C9—C4121.11 (12)C7—C6—H6119.8
C8—C9—C4122.15 (13)C8—C7—C6120.90 (14)
C3—C2—O3121.88 (12)C8—C7—H7119.6
C3—C2—C1122.80 (12)C6—C7—H7119.6
O3—C2—C1115.22 (12)O4—C10—O3121.89 (13)
C2—C3—C4119.40 (12)O4—C10—C11127.56 (15)
C2—C3—H3120.3O3—C10—C11110.52 (13)
C4—C3—H3120.3C12—C11—C10113.50 (15)
C9—C4—C5117.88 (12)C12—C11—H11A108.9
C9—C4—C3118.03 (12)C10—C11—H11A108.9
C5—C4—C3124.05 (12)C12—C11—H11B108.9
C7—C8—C9118.32 (13)C10—C11—H11B108.9
C7—C8—H8120.8H11A—C11—H11B107.7
C9—C8—H8120.8C11—C12—H12A109.5
O2—C1—O1118.14 (13)C11—C12—H12B109.5
O2—C1—C2125.74 (14)H12A—C12—H12B109.5
O1—C1—C2116.12 (12)C11—C12—H12C109.5
C6—C5—C4120.43 (13)H12A—C12—H12C109.5
C6—C5—H5119.8H12B—C12—H12C109.5
C1—O1—C9—C8179.07 (12)C9—O1—C1—C2−1.73 (18)
C1—O1—C9—C4−0.99 (18)C3—C2—C1—O2−176.26 (14)
C10—O3—C2—C3−113.91 (15)O3—C2—C1—O20.3 (2)
C10—O3—C2—C169.53 (17)C3—C2—C1—O13.69 (19)
O3—C2—C3—C4−179.09 (11)O3—C2—C1—O1−179.78 (10)
C1—C2—C3—C4−2.8 (2)C9—C4—C5—C6−0.27 (19)
O1—C9—C4—C5179.85 (11)C3—C4—C5—C6177.46 (12)
C8—C9—C4—C5−0.21 (19)C4—C5—C6—C70.4 (2)
O1—C9—C4—C31.98 (17)C9—C8—C7—C6−0.4 (2)
C8—C9—C4—C3−178.08 (12)C5—C6—C7—C8−0.1 (2)
C2—C3—C4—C9−0.08 (18)C2—O3—C10—O46.2 (2)
C2—C3—C4—C5−177.81 (12)C2—O3—C10—C11−175.47 (14)
O1—C9—C8—C7−179.53 (12)O4—C10—C11—C126.5 (3)
C4—C9—C8—C70.5 (2)O3—C10—C11—C12−171.65 (17)
C9—O1—C1—O2178.23 (13)
D—H···AD—HH···AD···AD—H···A
C8—H8···O2i0.932.593.4783 (19)161
C5—H5···Cg2ii0.932.783.4959 (16)134
  8 in total

1.  A short history of SHELX.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr A       Date:  2007-12-21       Impact factor: 2.290

2.  Detection of 4-hydroxycoumarin anticoagulants and their metabolites in urine as part of a systematic toxicological analysis procedure for acidic drugs and poisons by gas chromatography-mass spectrometry after extractive methylation.

Authors:  H H Maurer; J W Arlt
Journal:  J Chromatogr B Biomed Sci Appl       Date:  1998-09-04

Review 3.  Synthetic and natural coumarins as cytotoxic agents.

Authors:  Irena Kostova
Journal:  Curr Med Chem Anticancer Agents       Date:  2005-01

Review 4.  Simple coumarins and analogues in medicinal chemistry: occurrence, synthesis and biological activity.

Authors:  F Borges; F Roleira; N Milhazes; L Santana; E Uriarte
Journal:  Curr Med Chem       Date:  2005       Impact factor: 4.530

5.  Synthesis of 2,4,6-trisubstituted pyrimidines as antimalarial agents.

Authors:  Anu Agarwal; Kumkum Srivastava; S K Puri; Prem M S Chauhan
Journal:  Bioorg Med Chem       Date:  2005-08-01       Impact factor: 3.641

Review 6.  Studies on coumarins and coumarin-related compounds to determine their therapeutic role in the treatment of cancer.

Authors:  Aoife Lacy; Richard O'Kennedy
Journal:  Curr Pharm Des       Date:  2004       Impact factor: 3.116

7.  Crystal structure refinement with SHELXL.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr C Struct Chem       Date:  2015-01-01       Impact factor: 1.172

8.  Structure validation in chemical crystallography.

Authors:  Anthony L Spek
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-01-20
  8 in total
  2 in total

1.  Crystal structure of 2-oxo-2H-chromen-7-yl 4-fluoro-benzoate.

Authors:  Akoun Abou; Jules Yoda; Abdoulaye Djandé; Stéphane Coussan; T Jérémie Zoueu
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2018-04-27

2.  2-Oxo-2H-chromen-7-yl 4-tert-butyl-benzoate.

Authors:  Mohammad Ouédraogo; Akoun Abou; Abdoulaye Djandé; Olivier Ouari; T Jérémie Zoueu
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2018-03-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.